Temocillin for non-urinary tract infections caused by AmpC-producing Enterobacterales: Is it a feasible option?
{{output}}
Background: Infections due to AmpC-producing Enterobacterales represent an increasing therapeutic challenge. Third-generation cephalosporins may select resistant mutants, inducing clinicians to use cefepime or carbapenems and the... ...
